3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Acute
31
Burkitt Lymphoma
12
Myelodysplastic Syndromes
10
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Myeloproliferative Disorders
6
Leukemia, Biphenotypic, Acute
5
Lymphoma, Non-Hodgkin
4
Lymphoma, Mantle-Cell
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Myelomonocytic, Chronic
3
Leukemia
3
Down Syndrome
3
Blast Crisis
3
Sarcoma, Myeloid
2
Recurrence
2
Lymphoma, Follicular
2
Plasmablastic Lymphoma
1
Neoplasms
1
Myelodysplastic-Myeloproliferative Diseases
1
Lymphoma, T-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Lymphoma
1
Leukemia, Promyelocytic, Acute
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myeloid
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Monocytic, Acute
1
Hodgkin Disease
1
Interventions
Tretinoin
2
Arsenic Trioxide
2
arsenous acid
1
Mitoxantrone
1
Methotrexate
1
Mercaptopurine
1
Lisaftoclax
1
Idarubicin
1
Gemtuzumab
1
Cytarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leukemia, Promyelocytic, Acute
×
Cytarabine
×
30 days
×
Clear all
NCT02688140
2026-05-29
TUD-APOLLO-064
Technische Universität Dresden
Phase 3
Completed
133 enrolled